2023-04-12
Small
0personInquired
0personFavorited
ConnectType:
T - Technology & Patents
Industry:
Pharmaceuticals and Chemical IntermediatesFine Chemical ManufacturingEnvironmental Protection and Comprehensive Resource Utilization
Country / Region:
China
Company Type:
State-controlled enterprise
Registered Capital:
520 million RMB
Company Capability: Chemical Technology & Patents、Process Technology Development
Guangji Pharmaceutical (Jining) Co., Ltd. is a wholly owned subsidiary established in 2019 by Hubei Guangji Pharmaceutical Co., Ltd. (Stock Code: 000952.SZ) in the Caohe Town Industrial Park, Yanzhou District, Jining City, Shandong Province, with registered capital of RMB 150 million. It serves as a pivotal production base under Guangji Pharmaceutical’s strategic layout of “One Headquarters, Multiple Bases,” focusing on large-scale production and green manufacturing upgrades of vitamin B2 (riboflavin) and its key intermediates. The company’s core business encompasses research and development, production, and sales of food-grade and feed-grade vitamin B2; its products are widely applied by major domestic feed enterprises and food additive manufacturers, and are exported via the parent company to Southeast Asia, South America, and the Middle East. Leveraging its independently developed “microbial fermentation—directional crystallization—refined purification” process, the company demonstrates significant advantages in energy consumption control, product yield, and environmental friendliness; related technologies have been incorporated into Guangji Pharmaceutical’s “Key Green Biomanufacturing Technologies for Riboflavin” system. The enterprise has obtained certifications for ISO 9001 Quality Management System, ISO 22000 Food Safety Management System, and FAMI-QS European Feed Additive Quality System; it holds a Feed Additive Production License (Lu Si Tian [2022] T0332) and a Food Production License (SC12737088202595). Its project has received environmental impact assessment approval from the Shandong Provincial Department of Ecology and Environment (Lu Huan Shen [2020] No. 18) and completed environmental protection acceptance. The Jining base has a designed annual production capacity of 3,000 metric tons, making it Guangji Pharmaceutical’s second-largest riboflavin production base; it commenced formal operations in 2022 and is currently undergoing continuous capacity ramp-up. Areas of collaboration include customized supply of vitamin B2, technical cooperation in feed and food sectors, joint application of green processes, and OEM/ODM manufacturing services compliant with international quality standards.
Connect
More Suppliers科林能源技术(北京)有限公司
77
0
T - Technology & Patents
E - Engineering Design
P - Procurement
S - Site & Revamp
凯铭科技(杭州)有限公司
79
0
T - Technology & Patents
P - Procurement
Dalian Pace Gas Equipment Co., Ltd.
112
0
T - Technology & Patents
E - Engineering Design
P - Procurement
S - Site & Revamp





































